Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Genotype 1 Chronic Hepatitis C”

428 trials

Showing 20 of 428 results

Not applicableStudy completedNCT00709228
What this trial is testing

Study of Patients With Chronic Hepatitis C Infected With HCV LVL G1 and Effect of Peg-Intron Plus Rebetol Treatment (Study P04793)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 496
Large-scale testing (Phase 3)Study completedNCT01330316
What this trial is testing

A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients

Who this might be right for
Hepatitis C
Boehringer Ingelheim 119
Large-scale testing (Phase 3)Study completedNCT01973049
What this trial is testing

UNITY 2: A Study of an Investigational Treatment Regimen of DCV+ASV+BMS-791325 in a Fixed Dose Combination (the DCV 3DAA (Direct Acting Antiviral) Regimen) With or Without RBV for 12 Weeks for the Treatment of Chronic Hepatitis C Virus(HCV)Genotype 1 Infection in Subjects With Compensated Cirrhosis

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 202
Large-scale testing (Phase 3)Study completedNCT03833362
What this trial is testing

Efficacy and Safety of Narlaprevir Used in Combination With Ritonavir in Treatment-Naïve and Failed Prior Treatment With Pegylated Interferon/Ribavirin Patients With Chronic Hepatitis C Genotype 1 (PIONEER - Study)

Who this might be right for
Hepatitis C
R-Pharm 420
Large-scale testing (Phase 3)Ended earlyNCT01459913
What this trial is testing

Efficacy of a 12-Week Regimen of Telaprevir, Pegylated Interferon, and Ribavirin in Treatment-Naive and Prior Relapser Subjects With Interleukin28B (IL28B) CC Genotype

Who this might be right for
Hepatitis C, Chronic
Vertex Pharmaceuticals Incorporated 239
Not applicableStudy completedNCT02803138
What this trial is testing

Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin and Patient Support Program in Patients With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
AbbVie 256
Large-scale testing (Phase 3)Study completedNCT01716585
What this trial is testing

Evaluate Chronic Hepatitis C Infection

Who this might be right for
Chronic Hepatitis C Infection
AbbVie (prior sponsor, Abbott) 636
Post-approval studies (Phase 4)WithdrawnNCT03143998
What this trial is testing

Efficacy and Safety of Elbasvir/Grazoprevir in Brazilian Participants With Chronic Hepatitis C Virus (HCV) Genotype 1 Infection With Advanced Fibrosis (F3 and F4)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC
Large-scale testing (Phase 3)Study completedNCT03487107
What this trial is testing

Phase 3 Study of Yimitasvir Phosphate Capsules

Who this might be right for
Chronic HCV Infection
Sunshine Lake Pharma Co., Ltd. 362
Testing effectiveness (Phase 2)Study completedNCT01051414
What this trial is testing

An Anti-viral Combination Study With Japanese Hepatitis C Infection (HCV) Subject

Who this might be right for
Hepatitis C Infection
Bristol-Myers Squibb 43
Large-scale testing (Phase 3)Study completedNCT02114151
What this trial is testing

Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Participants With Genotype 1 Chronic Hepatitis C Virus Infection and Cirrhosis

Who this might be right for
Hepatitis C Virus Infection
Janssen Infectious Diseases BVBA 103
Testing effectiveness (Phase 2)Ended earlyNCT01080222
What this trial is testing

A Safety and Efficacy Study of the Combination of VX-222 and Telaprevir in Treatment-Naïve Subjects With Genotype 1 Chronic Hepatitis C Virus Infection

Who this might be right for
Chronic Hepatitis C Virus Infection
Vertex Pharmaceuticals Incorporated 152
Post-approval studies (Phase 4)Study completedNCT02759861
What this trial is testing

Determine the Efficacy and Safety of Harvoni in Genotype 1 Chronic Hepatitis c Infected People Who Are Alcoholics

Who this might be right for
Genotype 1 Hepatitis C Virus
University of Nebraska 16
Large-scale testing (Phase 3)Study completedNCT02822794
What this trial is testing

Sofosbuvir/Velpatasvir Fixed-Dose Combination and Ribavirin for 12 or 24 Weeks in Participants With Chronic Genotype 1 or 2 Hepatitis C Virus Infection Who Have Previously Failed a Direct-Acting Antiviral-Containing Regimen

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 117
Testing effectiveness (Phase 2)Study completedNCT03501550
What this trial is testing

Study of CDI-31244 in Combination With Sofosbuvir (SOF) and Velpatasvir (VEL)

Who this might be right for
Chronic Hepatitis C
Cocrystal Pharma, Inc. 12
Large-scale testing (Phase 3)Study completedNCT02358044
What this trial is testing

Efficacy and Safety of Combination Grazoprevir (MK-5172)/Elbasvir (MK-8742) Versus Sofosbuvir + Pegylated Interferon + Ribavirin in Hepatitis C Virus Genotype 1, 4 or 6 Infection (MK-5172-077)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 257
Large-scale testing (Phase 3)Study completedNCT02252016
What this trial is testing

Grazoprevir (MK-5172) and Elbasvir (MK-8742) Combination for Chronic Hepatitis C Virus (HCV) Genotypes 1, 4, and 6 (MK-5172-065)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 159
Large-scale testing (Phase 3)Study completedNCT02021656
What this trial is testing

Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination in Participants With Chronic Genotype 1 HCV Infection

Who this might be right for
Chronic HCV Infection
Gilead Sciences 384
Large-scale testing (Phase 3)Study completedNCT02399345
What this trial is testing

Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir Co-Administered With Sofosbuvir With and Without Ribavirin in Treatment-Naive HCV Genotype 1-Infected Adults

Who this might be right for
Chronic Hepatitis C Virus (HCV Infection Genotype 1)
AbbVie 10
Large-scale testing (Phase 3)Ended earlyNCT01500772
What this trial is testing

Alisporivir With PEG and RBV in Protease Inhibitor (PI) Treatment Failure Patients With Chronic Hepatitis C

Who this might be right for
Hepatitis C
Debiopharm International SA 6
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation